November 5, 2025 — Leads & Copy — Kinaxis® (TSX:KXS) reported its Q3 2025 results, with record new business driving accelerated ARR growth. Interim CEO Bob Courteau highlighted the successful launch of initial Maestro Agents, boosting planner productivity tenfold for a top-10 global pharmaceutical company.
Key Q3 2025 highlights include total revenue of $134.592 million (11% increase), SaaS revenue of $91.955 million (17% increase), and a gross profit of $85.949 million (13% increase). The company’s ARR rose to $407 million, a 17% increase. Kinaxis is updating its fiscal 2025 financial guidance, expecting total revenue between $535-550 million and adjusted EBITDA margin between 24-26%.
CFO Blaine Fitzgerald noted the company’s success in improving growth and profitability, expecting to exit 2025 with a higher ARR growth rate. The press release, financial statements, and MD&A are available on Kinaxis’ website and SEDAR+.
Kinaxis will host a conference call on November 6, 2025, at 8:30 a.m. Eastern Time, hosted by Bob Courteau and Blaine Fitzgerald. Registration details and webcast information are provided.
Bob Courteau, interim chief executive officer at Kinaxis.
Blaine Fitzgerald, chief financial officer at Kinaxis.
Source: Kinaxis Inc.
